A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
Clinical trial NCT06618001 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06618001
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-14
- Primary completion
- 2027-07-15
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.